GlassScriptPhysician profile
Michael Andrew Dever
NPI 1891282935
$4,313.81
in general payments reported to CMS, 2019-2025
8 companies · $1,720 in 2025
The $1,720 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.32 · 2022: $160 · 2023: $196 · 2024: $2,214 · 2025: $1,720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,360 · Food and Beverage: $1,762 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,360.38 |
| Food and Beverage | $1,761.74 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,567.38 | 2024-2025 | |
| Davol INC. | $324.14 | 2022-2025 | Phasix Mesh |
| Kerecis Limited | $263.21 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Kci USA, INC. | $101.63 | 2023 | V.A.C. Veraflo |
| Teleflex LLC | $18.29 | 2024 | Titan Sgs |
| Solventum Corporation | $15.84 | 2025 | Prevena, Activ.A.C. Ion Progress |
| Kls-Martin L.P. | $13.10 | 2019 | |
| Zoll Circulation INC | $10.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dever listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.